ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 218 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,245,562 | -75.4% | 118,738 | -69.2% | 0.00% | -80.0% |
Q3 2023 | $5,058,887 | +508.3% | 384,999 | +483.3% | 0.01% | +400.0% |
Q2 2023 | $831,701 | -69.5% | 66,008 | -57.2% | 0.00% | -71.4% |
Q4 2022 | $2,722,522 | +1254.5% | 154,338 | +1041.0% | 0.01% | +600.0% |
Q2 2022 | $201,000 | -71.5% | 13,527 | -56.8% | 0.00% | -50.0% |
Q1 2022 | $705,000 | -94.9% | 31,296 | -95.8% | 0.00% | -95.7% |
Q4 2021 | $13,726,000 | +1713.2% | 743,954 | +1214.5% | 0.05% | +1466.7% |
Q3 2021 | $757,000 | -26.4% | 56,597 | +2.0% | 0.00% | -40.0% |
Q2 2021 | $1,028,000 | -48.8% | 55,513 | -58.5% | 0.01% | -50.0% |
Q1 2021 | $2,009,000 | +279.1% | 133,815 | +264.5% | 0.01% | +233.3% |
Q4 2020 | $530,000 | +69.9% | 36,713 | -4.4% | 0.00% | +50.0% |
Q3 2020 | $312,000 | +39.9% | 38,383 | +16.3% | 0.00% | 0.0% |
Q2 2020 | $223,000 | -42.1% | 33,011 | -39.6% | 0.00% | -60.0% |
Q1 2020 | $385,000 | -90.9% | 54,696 | -87.4% | 0.01% | -80.0% |
Q4 2019 | $4,254,000 | +130.6% | 433,443 | +157.9% | 0.02% | +92.3% |
Q3 2019 | $1,845,000 | -57.7% | 168,058 | -55.2% | 0.01% | -53.6% |
Q2 2019 | $4,365,000 | -54.5% | 375,344 | -62.6% | 0.03% | -56.2% |
Q1 2019 | $9,586,000 | +59.0% | 1,004,793 | +60.7% | 0.06% | +48.8% |
Q4 2018 | $6,028,000 | +1399.5% | 625,335 | +2117.3% | 0.04% | +2050.0% |
Q3 2018 | $402,000 | -95.8% | 28,202 | -96.5% | 0.00% | -95.3% |
Q2 2018 | $9,570,000 | -25.3% | 797,472 | -23.1% | 0.04% | -20.4% |
Q1 2018 | $12,814,000 | -36.1% | 1,037,585 | -24.7% | 0.05% | -14.3% |
Q4 2017 | $20,045,000 | +764.8% | 1,377,630 | +658.3% | 0.06% | +530.0% |
Q2 2017 | $2,318,000 | +247.5% | 181,677 | +245.4% | 0.01% | +233.3% |
Q1 2017 | $667,000 | -81.8% | 52,600 | -85.3% | 0.00% | -85.0% |
Q4 2016 | $3,656,000 | -83.0% | 358,077 | -78.1% | 0.02% | -84.0% |
Q3 2016 | $21,563,000 | +13210.5% | 1,637,247 | +12739.1% | 0.12% | +12400.0% |
Q2 2016 | $162,000 | -96.4% | 12,752 | -96.5% | 0.00% | -97.0% |
Q3 2015 | $4,481,000 | -30.1% | 361,355 | -22.9% | 0.03% | -15.4% |
Q2 2015 | $6,410,000 | -33.8% | 468,597 | -42.1% | 0.04% | -50.0% |
Q1 2015 | $9,684,000 | +71.5% | 809,686 | +121.6% | 0.08% | +5.4% |
Q4 2013 | $5,648,000 | +170.9% | 365,335 | +126.7% | 0.07% | +111.4% |
Q2 2013 | $2,085,000 | – | 161,149 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |